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Interrogating fragment libraries by X-ray crystallography is a powerful strategy for discovering allostericl igandsf or protein targets.C ryocooling of crystals should theoretically increase the fraction of occupied binding sites and decrease radiation damage.H owever,i tm ight also perturb protein conformations that can be accessed at room temperature. Using data from crystalsm easured consecutively at room temperature and at cryogenic temperature, we found that transientb inding sites could be abolished at the cryogenic temperatures employed by standard approaches. Changing the temperature at which the crystallographic data wascollected could provide adeliberate perturbation to the equilibrium of protein conformations and help to visualize hidden sites with great potentialt oa llosterically modulate protein function.
Fragment-based ligand discovery( FBLD) uses small-molecule fragments (< 250 Da) to increase the probability of finding weak hits. [1] Additionally,t hese fragments have less molecular complexity and can therefore sample chemical space more efficiently than the larger molecules found in conventional highthroughput screening libraries. Successful FBLDc ampaigns have rapidly improved the affinity of these hits [2] and advanced severall ead molecules to modulate biology or disease.
[3] Fragment-screening methods, including surface plasmon resonance and NMR spectroscopy,can measurebinding affinities and provide initial structure-activity relationships (SARs). X-ray crystallographyp rovides key insights for FBLD by identifying the binding sites of hits and structurally guiding medicinal chemistry efforts to optimize the fit (and ultimately the affinity) between the ligand and the binding site. [4] Even weak affinity hits can be identified by mostF BLD X-ray crystallographye xperiments, because highly concentrated solutionsofligands are soaked into the protein crystal.The crystal is then cryocooled to protecta gainst radiation damage [5] and to halt any destructive effects of the solvent or ligands on the crystal lattice. [6] Cryocooling also offers tremendous benefits for the transportation of crystalsa nd automated crystal screening by using robotics. An additional,b ut rarely considered, potentiala dvantage of cryocooling is that thermodynamics favor ligand binding at lower temperatures. For example, given ad riving force of 2.16 kcal mol À1 for the standard Gibbs free energy of ligand binding (corresponding to a2 6mm K d at room temperature) and ac oncentrationo f3 3mm for the ligand soakedi nto the crystal,w ew ould expect the percentage of ligand-boundr eceptors to be 56 %a t2 93 K( room temperature), 88 %a t2 00 K( the glass-transition temperature), and 99.9 %a t1 00 K( cryogenic temperature;s ee the Supporting Information). Therefore, at high, but non-saturating, ligand concentrations, greater ligand occupancy at cryocooled temperatures would increase the observable electron density for weak ligandsatr eceptor binding sites.
In addition to active-site ligands, X-ray crystallographic fragment screens often identify hits to secondary binding sites that are distantfrom the active site andr equire protein conformationalf lexibility to become accessible to ligands. Initial hits can be subsequently refinedt oa ffect allosteric inhibition or activation,a sh as been demonstrated against targets such as HIV reverset ranscriptase [7] and 3-phosphoinositide-dependent kinase 1. [8] These "cryptic" bindings ites can be invisible to experimental techniques such as crystallography [9] because the energy gap between the pocket-forming( high-energy) state and the pocket-occluding (ground) state is too large.T herefore, identifying partially occupied ligandst hat show only weak electron density is especially importantw hen searching for allosteric modulators, because the electron density will reflect the equilibrium between the pocket-occluding and ligand-bound states. As for active sites of enzymes,cryocooling should increaset he fraction of ligandsb ound at the cryptic sites, which creates ap otentiala dvantage for identifying weak cryptic-site binders that can be developed to affect allosteric responses.
However,r ecent studies suggest that collection of X-ray diffraction data at cryogenic temperatures could mask alternate conformational states that are accessible to the protein at room temperature.
[10] By alteringt he equilibrium of protein conformations, cryocooling may therefore stabilize the pocketoccluding states of cryptic binding sites and oppose the pre-dicted enhanced ligand occupancy at lower temperatures. We have recently found that considering such high-energy/low-occupancys tates, which are present only at room temperature, can be essential for discovering new ligandsu sing flexible receptor docking. [11] This approachi dentified ligands that stabilize specific alternative loop conformationso fthe cavity site of cytochrome c peroxidase (CcP-ga). [11] Interestingly,i nt he apo structure (determined at cryogenic temperatures), the conformation that is preferred by the most potent compoundsi sn ot significantly populated. These results may also reflect nonequilibrium kinetic considerations of cryocooling, [12] because cryocooling may occurf aster than some protein conformational changes, ligand binding/dissociation events (k on /k off ), and ligand diffusion through vitrifying solvent channels.H erein, we have investigated the effect of cryocooling on fragment ligand-binding sites of CcP,o ne of which is ac ryptic site that is only observed upon ligand binding and is not visible in the apo structures. Our studies demonstrate how distinct binding sites can be differentially affected by the tradeoffsb etween enhancing ligand occupancy upon cryocooling and altering the population of higher energy conformational states that can present new ligand-binding sites.
To systematically probe the impact of temperature on fragment binding, we obtained crystallographic dataa tb oth cryogenic temperature and room temperature (RT) from single crystalsf or ligand-free (apo) CcP-ga and fived ifferent ligandbound CcP-ga complexes( Supporting Information). To minimize the difference between the datasets we 1) used 2-methyl-2,4-pentanediol (MPD) as ap recipitant and cryoprotectant to allow for the re-collection of data on the same crystal at cryogenic temperature, 2) collected data on the same crystal volume, 3) matched the crystal size to the synchrotron beam size. This approach minimizes differences in the chemical compositiono ft he crystal, local differences in crystal quality,a nd differences in the distribution of soakedc ompounds, respectively.F or each crystal, we first measured the diffraction pattern at RT,a nd then, after flash-cooling the crystal in liquid nitrogen, we re-measured the diffractionp attern of the same crystal at cryogenic temperatures. Changes in the resolution and mosaicity were minimal and typical for well-cooled crystals (Supporting Information, Table S3 ). Using the same method, we also managed to collect eight complete RT datasetso nt he same crystal volume, three of which wereb efore the data quality decreased to below 2.1 ( see also the Supporting discussion and Supporting Information, Figure S8 ). To compare the structural impact of cryocooling and ligand binding, we calculated the distance of each protein residue from the protein center-of-mass as afunction of temperature and as af unction of ligand state (bound or apo). The distribution of differences between these distances (e.g.,C cP-ligand1 at RT-CcPligand1a tc ryogenic temperature) provides an estimate of the anisotropy of the structural perturbation of the protein. [13] Althoughc onformational changes are required to accommodate differentl igands, [11] we found that the protein structure is more perturbed by temperature than by ligand binding (Figure 1A ;F igure S1 and Ta ble S8).
For example, the peaks of the distributions comparing datasets at two different temperatures (RT versus cryogenic) with the same ligand state are offset from zero, which shows that there is thermalc ontraction of the protein. Also, the distributions are broad,w hich indicates that there is heterogeneityi n the structures ( Figure 1A ). Comparing the apo to the ligandbound protein structures at the same temperature reveals that peaks are centered at zero. However,t he distributions are much narrower at RT than at cryogenic temperatures, which indicates ad ecreasei np recision at cryogenic temperature, commonly defined as an increasei nr andome rrors. Note that the observed decrease in the atomic displacement distributions [12] (B factors) observed at cryogenic temperatures would normally be interpreted as evidencef or increased precision (TablesS1a nd S2). A) The distance of each protein residuef rom the protein center-of-massi scompared between two structures either at different temperatures (green line) or in different ligand states (apo versus with benzimidazole) at the sametemperature (red = RT and blue = cryogenic temperature). All temperature pairs were collectedc onsecutively on the samecrystal. The amountofo ffset from zero reflects the expected thermal contraction of the protein upon freezing (green line). The broader distributions indicate structural heterogeneity upon ligand binding at cryogenic temperature (blue line) and structural heterogeneity of the same structure collected at different temperatures (green line). The narrow distribution of the different ligand states at RT (red line) suggests that, at cryogenic temperature, the protein structure is non-specifically perturbed by cryocooling ratherthan showingaresponseu nique to ligand binding. B) Multiple protein sitesdisplay ligand electron density at different temperatures. Electron densityw as observed at both RT (red mesh) and cryogenic temperature( blue mesh) for the primary cavity site and the M119 surface site,whereas the heme proximal d-site andthe H96 crypticbinding site are temperature sensitive.
ChemBioChem 2015, 16,1560 -1564 www.chembiochem.org However,t he broad distributions of the cryocooled structures suggest much larger structural differences, which are likely due to nonspecific perturbations caused by the cryocooling process and not due to ligand binding. In contrast, the comparisons between the RT structures isolate those structural responses that are uniquet ol igand binding. Thisd iscrepancy between the RT and the cryogenic data is counterintuitive, because we would expect dissimilarities to be amplified between the ligand-stabilized and the ligand-free structuresu pon increasingt he thermal motion at RT.T hese resultsi ndicate that cryocooling can have al arge and inconsistent impact on the conformations of residues throughout the protein (Figure S2 ), which may misinform structure-based drug andp robe design.
Next, we examined the binding site and other protein regions for large temperature-dependent changes in electrondensity distributions.F or the ligand benzimidazole, as expected, we observed consistente lectron density for the ligand at both temperatures for the primary binding site. [11] We were surprised to observe ligand density at three additional distal sites ( Figure 1B) . As with the primary binding site, ligand electron density appears at both temperatures in as econd, surface-exposed site near Met119 ( Figures 1B;F igure S3 B) . In a third site, near the d-heme edge, ak nownC cP substrate site, [14] we observed ligand density only at cryogenic temperatures and not at RT ( Figures 1B;F igureS3A) . Benzimidazole also occupied af ourth site, near His96,b ut only at RT (Figures 1B and 2 ). This fourth site can be classified as ac ryptic site because the bindingp ocket is not apparent in the apo structurea te ither room-or cryogenic temperature. Access of the ligand to this cryptic site is controlled by an alternative conformation of His96, which is correlatedw ith the presence of the benzimidazole (Figure 2 ) and can be identified by as econdary electron-density peak using Ringer [15] (Figure 2A ). Althought he cryogenic data were collected on the same crystal volumea st he RT data, the cryogenic temperaturee lectrondensity maps are consistento nly with the "closed" His96 rotamer and three water molecules occluding the cryptic site (Figure 2B ). This result illustrates how the population of alternative conformations can be perturbed by temperature,t hus altering the potentialf or observing al igand in ab inding pocket (Figure 1B) .
To probe the biological relevance of the cryptic bindings ite, we movedf rom the CcP-ga model system, which has ac avity engineered to bind small molecules, [11, 16] to CcP-wt, which contains the radical-forming Trp191 residuet hat is involved in long-range electron transfer at the active site. [17] We first confirmed that benzimidazole occupied the cryptic binding site in CcP-wt. Co-crystals with benzimidazole diffracted to ar esolution of 2.6 a nd showed electron density for the ligand in the cryptic binding site for three of the four protein copiesw ithin the crystallographic asymmetric unit.
Refinement of the data unambiguously revealed His96 to be in an open state ( Figure S4 ), but no ligand density at the Met119 residue or d-site could be detected at this resolution. To determine the binding affinity of benzimidazole to the cryptic binding site, we monitoredl igand bindingt hrough the saturable perturbation of the CcP heme Soret band.
[16b] In the CcP-ga cavity site, benzimidazole can occupym ultiple sites and has low micromolar affinity for the primary binding site ( Figure S5 ). However,i nt he wild-type protein, Trp191 blocks this high-affinity binding site, which allowed us to isolate the bindinga ffinity of benzimidazole to the lower affinity site. We determined an affinity of benzimidazole for CcP-wt of 26 mm ( Figure S6 ), which corresponds to al igand efficiency( LE) [18] of 0.24 kcal mol À1 per ligand heavy atom (HA;F igure2A). Given that the cryptic site is too far away (25 ) from the heme to elicit ad irect Soret shift, we werei nitially surprised to observe an allosteric Soret band shift for benzimidazole. Although we detectedn os teric coupling networks connecting the cryptic binding site to the heme by using CONTACT [19] in our CcP-ga crystal structures at RT (FigureS7), arecent EPR study proposes the cryptic binding site to be ab iologically relevant site for substrate oxidationt hat is remote from the heme. [20] This alternative electron transfer pathway includes the nearbyT yr71 res- www.chembiochem.org idue as ar eactive intermediate [20] and contrasts with am odel where small-molecule binding to sites other than the d-heme edge was suggested to be nonspecific. [21] The discrepancy between ab inding site being occupied by benzimidazole at RT andu noccupied in the same crystal at cryogenic temperature is counterintuitivea nd suggests that cryocooling can "overwhelm" the driving forces of ligand binding. To explain the reduction of benzimidazole occupancy from approximately 50 %a tr oom temperature to below the detection limit of about 5% at cryogenic temperature, cryocooling must counteract the temperature-dependent effects on the ligand-protein equilibrium. To estimate the penalty on occupancy from cryocooling, we assumeb oth cryocooling and ligand soaking to be at equilibrium, although the heterogeneous structuralp erturbations we observed in response to cryocooling could suggest that the system has not equilibrated at the cryocooled temperature. However,o nt he typical timescale of freezing (100 ms), [12] we are neither in the fast-cooling regime where RT states are frozen-in nor in the slow-cooling regime where the crystal has had time to equilibrate. Therefore, intermediate states of slow and fast equilibrating domains are likely differentially trapped. Wer elatedt he energy penalty (DG)a safunctiono fl igand-soaking concentration [L],s tandard affinity at room temperature (K dsite ), minimum detectable occupancy (occ min ), temperature T,and the gas constant R:
See Supporting Information for the derivation of this equation. Given our experimental conditions of soakingaligand with a K d of 26 mm at ac oncentration of 33 mm and crossing the glass-transitiont emperature of 200 Ku pon cooling, the allosteric cryocooling penalty mustb ea tl east 1.3 kcal mol À1 to render the ligand invisible below 5% occupancy.T he cryocooling penalty includes the solvent glass transition, unusualt emperatured ependencies of other enthalpic or entropict erms, and allosteric lattice changes to the protein ensemble. All of these mechanismsa re likely to be important for increasing the magnitude of the cryocooling penalty of CcP residue His96. [12] In contrastt ot he behavior of benzimidazole at the cryptic binding site, we identified two examples where the cryocooling penalty does not dominate over other contributions to binding.F irst, 2-amino-5-methylthiazole binds to the cryptic binding site at both temperatures ( Figure 3A) . When the soaking concentration is 100 mm,2 -amino-5-methylthiazole (k d = 68 mm;L E= 0.22) shows higher crystallographic occupancy at cryogenic temperatures than at RT (75 %v ersus 54 %, respectively;F igure 3A); this mirrors our expectation of 99.6 %o ccupancy at 100 Kand 59 %occupancy at 298 K. Second, cryocooling can promote compounds to bind to other sites that do not requireaconformational change to form ap ocket. For the dsite, for example, we only observed benzimidazole density at cryogenic temperatures ( Figures 1B and S3 ). Based on these results, which suggestt hat the cryocooling penalty would disfavor binding at the cryptic site, and the fact that the Protein Data Bank is dominated by data collected at cryogenic temperatures, [5] we expected to find more d-site binderst han cryptic site binders in the previously determined structures. We inspected1 36 electron-density maps of previously determined structures of three CcP variants( CcP-wt,C cP-W191G, CcP-ga) from the PDB and struggled to find significant electron density in the d-site, whereas we found severale xamples of ligand densitiesi nt he cryptic binding site ( Figure 3B ). Counterintuitively,t his suggests al ower driving force for ligandst ob ind to the d-site. Because the d-site is accessible withoutl ocal sidechain conformational changes, the lower observed frequency might also hint at allostericl attice effects that reduce binding at this site. Collectively,t hese results illustrate how cryocooling can have counteracting effects on ligand occupancy at fragment-binding sites.
Heterogeneous and non-equilibrium contributionst op rotein-ligand interactions upon cryocooling make it difficult to assign an exact value for this penalty beyond our previously mentioned estimate of 1-2 kcal mol
À1
.H owever,o ur observations illustrate that the cryocooling penalty plays ad ominant role in determining the net binding of aligand in acryogenically frozen protein.
Our observation that the cryptic binding site was occupied at RT but not at cryogenic temperature contradicts the thermodynamic expectation that ah igher fraction of sites should be bound at cryogenic temperatures. This suggestss hifting temperatures as ag eneral strategy to modulate the energy landscape of protein-ligand bindinga nd overcome cryocooling penalties in favor of populating and revealing transient sites. We note that these cryocooling effects can be especially www.chembiochem.org problematic at ligand concentrations around or below the K d , which equals the ligand concentration at which half of the protein molecules are bound. Although the observation of differential binding dependso nalucky choice of concentration and compound soaking time, as for benzimidazole in CcP-ga, the chance of observing as econdary ligand-binding site increases with concentration-at both temperatures. Fragments will be particularly affected, because they intrinsically achieve low binding affinitiese ven at high ligand efficiencies,a nd the penalties may therefore overwhelm binding upon cryocooling. To counteract this effect, very high soaking concentrations would have to be used to achieveas ufficient fraction of receptors bound to al igand.H owever,p reparing such high concentration stock solutions is often impractical, because it is limited by the solubility of compound and the sensitivity of the protein to organics olvents (like DMSO)o rt he compound itself.
Allosteric ligand-binding sites offer great potential for modulating protein function, but are often difficult to visualize. However,c ryptic binding sites, with the potential to allosterically modulate protein function,c an be discovered serendipitously, even for well-studied proteins, by using af ragment-based approach.H erein, we demonstrate that shifting the temperature at which the crystallographic data are collected can deliberately perturb the protein to help visualize such cryptic binding sites. To shift the population of conformational states towards the energetically less-accessible states and detect new binding sites for low-affinity,l ess-soluble fragments, we suggest ad ual strategy: collect both datasets, if possible. This approach will complementm utagenesis efforts designed to stabilizes pecific protein conformations and may help identify cryptic binding sites, which could substantially extend the targetst hat can be probedt od issect biological mechanisms or enablet herapeutic intervention. [9, 22] For fragments, rather than invalidatingc ryogenic data, RT data collection has potentiala sa no rthogonal methodt hat could unleash some of the unused potential within FBLD. However, even without RT data, we suspect that many existing electron-density maps may contain evidenceo f unmodeled ligands partially occupyings uch sites;e specially when high concentrations of ligand were used to soak the crystals, as is typical of fragment-based methods.W hile we cannotl ink remote bindings ites to function from structure alone, FBLD-investigators specifically lookingt of ind or optimize allosteric binding ligands may find promise in exploring the full landscape of ligand binding.I nt hose cases, our strategy of shiftingc onformational equilibria by shifting temperature may becomeilluminating,even crucial.
Experimental Section
Experimental details are given in the Supporting Information.
